Women’s Health Study - Customer Case Study

A ActiGraph Case Study

Case study describing how Women’s Health Study used ActiGraph

This landmark study conducted by Brigham and Women’s Hospital and Harvard Medical School began in 1993 as randomized trial of low-dose aspirin and vitamin E supplementation for cardiovascular disease and cancer prevention in nearly 40,000 female health professionals aged 45 and older. The trial concluded in 2004, and the WHS has now evolved into one of the largest and longest-running observational studies of women’s health in the U.S. An ancillary study examining physical activity and health outcomes is currently underway involving approximately 30,000 women from the original trial. ActiGraph GT3X+ devices are being used to objectively measure physical activity for 7 days in study participants.


ActiGraph

22 Case Studies